As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Senators question Pfizer's partnership with UpScriptHealth, citing potential anti-kickback concerns and risks of increased ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

U.S. District Judge M. Casey Rodgers, accused in a misconduct complaint two weeks ago of showing preference to women, gave ...

John Kenney Jr., MD, Lifetime Achievement Award and Lectureship recipient Pearl E. Grimes, MD, FAAD, delivered a tribute to her predecessor as she discussed the history and advancements of vitiligo.

The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...

Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...